Chunghwa Chemical Synthesis & Biotech (1762.TW) Earnings Analysis
Chunghwa Chemical Synthesis & Biotech (1762.TW) next reports earnings on 2026-08-11. Last quarter (2026-03-05) it missed with EPS -2.55 TWD vs -0.2 TWD est (-1175%). It has beaten estimates in 0/4 recent quarters (0%). Trailing P/E -11.94.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 1762.TW next report earnings?
| Next earnings date | 2026-08-11 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
1762.TW earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-05 | -2.55 TWD | -0.2 TWD | -1175% | Miss |
| 2025-08-07 | -1.21 TWD | -0.22 TWD | -450% | Miss |
| 2025-03-06 | -0.01 TWD | 1.2 TWD | -100.8% | Miss |
| 2024-11-11 | -0.11 TWD | 0.66 TWD | -116.7% | Miss |
Beat rate: 0/4 (0%) over reported quarters with consensus data.
1762.TW valuation and analyst view
| Trailing P/E | -11.94 |
|---|---|
| Trailing EPS | -2.9064 TWD |
| Price / book | 0.60 |
| Dividend yield | 0.56% |
| Market cap | 2.68B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Chunghwa Chemical Synthesis & Biotech (1762.TW)'s next earnings date?
Chunghwa Chemical Synthesis & Biotech is next scheduled to report on 2026-08-11.
Did 1762.TW beat earnings last quarter?
In its 2026-03-05 report, 1762.TW posted EPS of -2.55 TWD versus a -0.2 TWD estimate — a miss of 1175%.
What is 1762.TW's earnings track record?
Over the last 4 reported quarters with consensus data, 1762.TW beat estimates 0 times (0%).
What is 1762.TW's current P/E ratio and EPS?
1762.TW trades at a trailing P/E of -11.94 on trailing EPS of -2.9063987691193773 TWD.
What do analysts rate 1762.TW?
1762.TW has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.